Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Assay of plasma heparin using thrombin and the chromogenic substrate H-D-Phe-Pip-Arg-pNA (S-2238).

× No keyword cloud information.

12 in total

1. The influence of Org 10172, a low molecular weight heparinoid, on antipyrine metabolism and the effect of enzyme induction on the response to Org 10172.

Authors: A De Boer; J C Stiekema; M Danhof; D D Breimer
Journal: Br J Clin Pharmacol Date: 1991-07 Impact factor: 4.335

2. Investigations on plasma activity of low molecular weight heparin after intravenous and oral administrations.

Authors: M Dryjski; D E Schneider; P Mojaverian; B S Kuo; T D Bjornsson
Journal: Br J Clin Pharmacol Date: 1989-08 Impact factor: 4.335

3. Safety and pharmacokinetics of the low molecular weight heparinoid Org 10172 administered to healthy elderly volunteers.

Authors: J C Stiekema; H P Wijnand; T G Van Dinther; H C Moelker; J Dawes; A Vinchenzo; H Toeberich
Journal: Br J Clin Pharmacol Date: 1989-01 Impact factor: 4.335

4. Detection of glycosaminoglycans on the surface of human umbilical vein endothelial cells using gold-conjugated poly-L-lysine with silver enhancement.

Authors: N J Klein; G I Shennan; R S Heyderman; M Levin
Journal: Histochem J Date: 1993-04

5. A cross-over comparison of the anti-clotting effects of three low molecular weight heparins and glycosaminoglycuronan.

Authors: J C Stiekema; J M Van Griensven; T G Van Dinther; A F Cohen
Journal: Br J Clin Pharmacol Date: 1993-07 Impact factor: 4.335

6. The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression.

Authors: B A Konkle; D Ginsburg
Journal: J Clin Invest Date: 1988-08 Impact factor: 14.808

7. Studies of interaction of a low-molecular-weight heparinoid (Org 10172) with cloxacillin and ticarcillin in healthy male volunteers.

Authors: A de Boer; J C Stiekema; M Danhof; T G van Dinther; J K Boeijinga; A F Cohen; D D Breimer
Journal: Antimicrob Agents Chemother Date: 1991-10 Impact factor: 5.191

8. Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group.

Authors:
Journal: Arch Orthop Trauma Surg Date: 1992 Impact factor: 3.067

9. Interaction of ORG 10172, a low molecular weight heparinoid, and digoxin in healthy volunteers.

Authors: A de Boer; J C Stiekema; M Danhof; A J Moolenaar; D D Breimer
Journal: Eur J Clin Pharmacol Date: 1991 Impact factor: 2.953

10. Fibers Generated by Plasma Des-AA Fibrin Monomers and Protofibril/Fibrinogen Clusters Bind Platelets: Clinical and Nonclinical Implications.

Authors: Dennis K Galanakis; Anna Protopopova; Liudi Zhang; Kao Li; Clement Marmorat; Tomas Scheiner; Jaseung Koo; Anne G Savitt; Miriam Rafailovich; John Weisel
Journal: TH Open Date: 2021-07-06